Did not become law. It stopped in the House of Representatives's Public Health Committee on February 8, 2019. The 2019 session has ended.
2019 Regular Session
House Bill 6872
AN ACT CONCERNING THE LABELING OF PRESCRIPTION DRUG CONTAINERS CONTAINING OPIATES.
What it does
The synopsis the General Assembly published with the bill.
To inform patients regarding the potency and possible negative consequences of taking prescription opiate drugs.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
Its course
January 30 to February 8, 2019, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action4 actions on 3 days
In the House of RepresentativesJan 30 to Feb 8 · stopped9 days
General Law CommitteeJan 30 to Feb 7 · moved on8 days
Public Health CommitteeFeb 7 to Feb 8 · stopped1 day
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the House of Representatives Jan 30 – Feb 7
- Jan 30Introduced and sent to General Law Committee
- Feb 7Sent to Public Health Committee
All 4 actions, as published
- Jan 30REF. TO JOINT COMM. ONBoth houses
- Feb 7Change of ReferenceBoth houses
- Feb 8CHG. REF., HOUSE TO COMM. ONHouse of Representatives
- Feb 8CHG. REF., SEN. TO COMM. ONSenate